Year To Quarter End Consolidated Statement Of Comprehensive Income

Daito Pharmaceutical Co., Ltd. - Filing #7579309

Concept 2022-06-01 to
2022-11-30
2021-06-01 to
2021-11-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
1,724,000,000 JPY
2,760,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
305,000,000 JPY
-129,000,000 JPY
Foreign currency translation adjustment
96,000,000 JPY
19,000,000 JPY
Remeasurements of defined benefit plans, net of tax
38,000,000 JPY
3,000,000 JPY
Other comprehensive income
440,000,000 JPY
-106,000,000 JPY
Comprehensive income
2,164,000,000 JPY
2,653,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
2,176,000,000 JPY
2,665,000,000 JPY
Comprehensive income attributable to non-controlling interests
-11,000,000 JPY
-11,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.